Spes article 2
A Chinese Herbal Formula for the
Treatment of Pain and Associated
Symptoms of Cancer
Dr. Sherman Shu-Seng Lai
C.M.D., Dr.Ac.. B.Sc.
Oriental Healing Arts and Health Institute
15 Surrey St. W. Guelph, Ontario, Canada NIH-3R3
THE 1995 TORONTO CONFERENCE OF THE WORLD
ASSOCIATION OF CHINESE MEDICINE
Approximately 8 million new cases of Cancer are reported yearly. Present mainstream methods
of cancer pain control have offered at best disappointing results, as they are usually accompanied
by adverse side-effects and drug dependency.
As an alternative approach, acupuncture, while proven effective for cancer pain, is often not
accessible to cancer patients, who suffer from the associated symptoms of nausea, fatigue,
insomnia and weakness.
Recognizing these facts, the World Health Organization (WHO) has made the control of cancer
pain a primary objective for the year 2000, stipulating a
preference that a safe, oral, fast-acting, effective treatment with few or no side-effects be
available to those afflicted.
The objectives of the Present clinical trials are threefold: to use accessible, alternative, natural
Chinese herbal formula SPESTM to provide relief from i) cancer pain, ii) the disease-associated
symptoms of fatigue, nausea, loss of appetite, insomnia and general debility, and iii) to suppress
further cancer metastasis.
Forty cancer subjects received SPESTM orally for a two month course of treatment. Results
indicate. that of the subjects treated, 74% had significant pain relief, 88% had significant
improvement in one or more of the disease-associated symptoms, and four cases of cancer were
found to be in remission. Results also indicated that overall quality of life for SPESTM patients
improved almost immediately - within 24 to 48 hours of starting on SPESTM: 88% of the subjects
reported improvement with the symptoms and/or pain associated with cancer.
Overall, these preliminary results demonstrate SPESTM to be an effective, quick-acting natural
treatment for controlling cancer pain, reducing the associated symptoms, and suppressing
metastasis. SPESTM appears to be a valuable alternative treatment for those afflicted with
cancer: it is accessible to patients and is without the adverse side-effects and dependency factors
associated with many other medical treatments for cancer.
Key words- Cancer symptom relief, metastasis suppression, Chinese herbal formula, SPESTM
Control Of Cancer Pain Must be of Paramount concern, considering the millions, afflicted with
this devastating disease, Recognizing that approximately eight million cases of cancer are being
reported yearly, the World Health Organization has stipulated that health scientists must find a
safe, oral, fast-acting. effective treatment, with little or no side-effects for eliminating cancer
The purpose of the present clinical trials is to evaluate the efficacy of a Chinese herbal formula
SPESTM (see APPENDIX A) with respect to its ability to: i) significantly reduce cancer
associated pain, ii) significantly relieve cancer associated symptoms such as fatigue, weakness,
nausea, insomnia, and loss of appetite, and iii) to
suppress further cancer metastasis.
Forty cancer patients, both female and male, were surveyed subsequent to receiving SPESTM
treatment. Each patient had been diagnosed with one of the fourteen types of cancer surveyed
(see APPENDIX B), ranging from cancer's early to terminal stages. The subject's ages ranged
from 19 years to 80 years. Prior to receiving SPESTM treatment patients reported having pain and
one or more of the cancer associated symptoms.
Each of the forty subjects was treated orally with the SPESTM Chinese herbal formula. Two 300
mg capsules were ingested by subjects B.I.D. (twice per day), 2 capsules a.c. in the a.m. (before
a meal), and 2 capsules a c. in the evening (before a meal). The course of treatment for subjects
ranged from seven days to four months, with the average treatment length being two months time.
Subsequent to SPESTM treatment each subject was evaluated using the SPESTM Patient
Questionnaire (see APPENDIX C) to determine overall efficacy of the product with respect to
pain and associated cancer symptom relief, as well as to record cases of metastasis suppression.
Preliminary results of the present clinical trials indicate the following:
Cancer Associated Pain: of the twenty three subjects treated, seventeen(74%) reported
significant pain relief
Cancer Associated Symptoms: of the forty subjects treated (88%) reported significant
improvement in one or more of the associated symptoms. Improvement measured by a positive
change of 50% or more in associated symptoms. (APPENDIX D).
Metastasis Suppression: of the forty subjects treated, four were confirmed subsequent to SPESTM
treatment as being in complete remission.
Clinical trial results also demonstrate that overall quality of life for 88% of the SPESTM subjects
improved within 24 to 48 hours of starting SPESTM.
INTERPRETATION AND DISCUSSION:
Chinese herbs have long been used in the treatment of cancer but little Scientific research has
been done to evaluate their effect.
It is always difficult to evaluate treatment of any disease such as cancer when the disease itself
remains poorly understood. Design of a rigorously controlled
research trial is seriously hampered and unethical not only because the disease's cause remains
obscure but also because, placebo testing is inappropriate with regard to the serious and terminal
conditions faced by those patients with cancer.
The present clinical trials, while preliminary in nature and based on a small sample of patients,
seem to indicate that effective treatment for cancer associated pain and symptoms may be
available through an oral treatment program of the Chinese herbal formula SPESTM.
In 74% of the sample cases, SPESTM treatment appears to have successfully met the mandate
and objectives set forth by the World Health Organization for effective cancer pain relief. The
present clinical trials have found SPESTM to be fast-acting. Positive results for both cancer
associated pain and symptom relief were reported within 24 to 48 hours of treatment onset.
Comparatively, few other modes of treatment provide such dramatic relief for cancer associated
pain and symptoms within such a short time frame.
Also significant is the fact that within these clinical trials no adverse side effects were reported
found. This finding suggests an advantage to using SPESTM over other conventional treatments
such as morphine; which often elicits adverse side effects such as drug dependency, respiratory
decreased mental alertness. SPESTM administration was also observed to minimize the adverse
effects often associated with such therapies as chemotherapy and radiation. This may indicate a
valuable role in alleviating discomforts associated with more aggressive treatment regimens.
SPESTM treatment may also be advantageous over other alternative treatments such as
acupuncture, because of its accessibility. Cancer patients who are weak,
debilitated, and nauseous may not be strong enough to receive the benefit of acupuncture but are
easily able to receive SPESTM. orally (or in more terminally ill cases rectally) regardless of the
type or stage of cancer.
Another characteristic of SPESTM that may make it an attractive alternative to other cancer treatments is the finding that significant
improvement was not just limited to the cancer associated pain relief itself. In the present clinical
trials, 88% of the patients also found significant improvement in their cancer associated
symptoms, such as improved sleep patterns, and Increased appetite and energy levels. The
benefit suggested here is that SPESTM ,as a single treatment mode may be more diverse in its
applications for those afflicted with cancer.
Perhaps, the most interesting observation in this study was that four of the patients confirmed that
their cancer was in complete remission after the use of SPESTM. The implications of this
observation are threefold: 1) SPESTM may play an important role in suppressing further cancer
metastasis, 2) SPESTM may completely reverse the cancerous condition, and 3) SPESTM is
deserving of more serious attention and study amongst the scientific health community.
In Summary, the author of this paper would like to reiterate that because of the preliminary
nature of this study, and the small size of the clinical sample, it is hoped that future research and
evaluation of SPESTM will result.
It is unfortunate, that millions of people suffer and die each year, as a result of the devastating
far-reaching effects of cancer. SPESTM is an encouraging Chinese herbal formula that appears to
greatly improve the quality of life for those under its treatment.
Composition of SPESTM
|Agrimonia pilosa Ledeb.|
|Cervus nippon Temminck|
|Glycyrrhiza uralensis Fisch.|
|Pyrola rotundifolia L.|
|Stephania sinica Diels|
|Stephania delavayi Diels|
Case Study Information
|Number of Cases:
|Number of Cases Male:
|Number of Cases Female:
|Age Group Range of Study Participants:
||19 years to 80 years|
|Average Age of Study Participants:
|"Types of Carcinoma Treated with of SPESTM"
||Number of Cases|
Patient Responses To SPESTM Treatment
N = Total Cases = 40
No. of Patients
|Y/X x 100 =
||Average of |